NCT06404697View on ClinicalTrials.gov

Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2030

Conditions
Breast Cancer
Interventions
RADIATION

Boost irradiation

High-risk patients will undergo boost irradiation to the SCV with a cumulative dose of ≥60 Gy.

Trial Locations (1)

Unknown

RECRUITING

Ruijin hospital, Shanghai jiaotong university school of medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER